封面
市場調查報告書
商品編碼
1607936

心臟心律不整監測設備的全球市場:產業分析,規模,佔有率,成長,趨勢,預測(2024年~2031年)

Cardiac Arrhythmia Monitoring Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日期: | 出版商: Persistence Market Research | 英文 269 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

2024年全球心律不整監測設備市場規模預估為84.932億美元,2024-2031年預測期間複合年增長率為7.80%,2031年將達到143億美元。

心律不整監測設備是診斷和治療心律不整的重要工具。這些設備用於追蹤心律、檢測異常並及時採取乾預措施來控制心律不整。市場上有許多不同類型的設備,包括動態心電圖 (ECG) 機和植入式心臟監視器,這些設備正在幫助醫療保健提供者改善患者治療效果並監測心臟健康狀況。

由於多種因素,包括心臟病患病率的上升、對心律不整的認識不斷增強以及醫療技術的進步,全球心律不整監測設備市場正在強勁增長。更容易患心血管疾病的老化人口的增加,正在進一步加速市場需求。此外,醫療保健支出的增加、醫療基礎設施的改善以及穿戴式健康監測設備的日益普及也極大地促進了市場的擴張。採用遠距醫療和遠端監測進行心律不整管理也在市場擴張中發揮關鍵作用,特別是在服務不足的地區。

心律不整監測設備市場提供了巨大的成長機會,特別是透過開發提供即時監測和數據共享功能的便攜式和可穿戴設備。個人化醫療保健的日益增長的趨勢,加上分析心律不整資料的人工智慧和機器學習的進步,將為監測設備的創新開闢新的途徑。此外,設備製造商和醫療保健提供者之間越來越多的合作夥伴關係提供整合解決方案並增強患者護理,這為市場參與者提供了另一個充滿希望的機會。

本報告提供全球心臟心律不整監測設備市場相關調查,提供各產品類型,各用途,各終端用戶,各地區趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場簡介

第3章 心律不整監測設備市場觀點

第4章 北美的心臟心律不整監測設備市場分析(2019年~2023年)及預測(2024年~2031年)

第5章 南美的心臟心律不整監測設備市場分析(2019年~2023年)及預測(2024年~2031年)

第6章 歐洲的心臟心律不整監測設備市場分析(2019年~2023年)及預測(2024年~2031年)

第7章 亞太地區的心臟心律不整監測設備市場分析(2019年~2023年)及預測(2024年~2031年)

第8章 中東·非洲的心臟心律不整監測設備市場分析(2019年~2023年)及預測(2024年~2031年)

第9章 競爭情形

  • 市場結構
  • 競爭儀表板
  • 企業簡介(詳細內容- 概要,財務,策略,SWOT,最近的趨勢)
    • NUUBO Smart Solutions Technologies, SL
    • Koninklijke Philips N.V.
    • GE Healthcare (General Electric Company)
    • Welch Allyn - A Hill-Rom Inc. Company
    • Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
    • Nihon Kohden Corporation
    • Fukuda Denshi Co., Ltd.
    • Biotelemetry, Inc.
    • AliveCor, Inc.
    • Biotronik, Inc.
    • Medronic, Plc.
    • St. Jude Medical, LLC. (Abbott Laboratories)

第10章 全球心臟心律不整監測設備市場分析(2019年~2023年)及預測(2024年~2031年),各地區

第11章 全球心臟心律不整監測設備市場分析(2019年~2023年)及預測(2024年~2031年),各產品類型

第12章 全球心臟心律不整監測設備市場分析(2019年~2023年)及預測(2024年~2031年),各用途

第13章 全球心臟心律不整監測設備市場分析(2019年~2023年)及預測(2024年~2031年),各終端用戶

第14章 全球心臟心律不整監測設備市場分析(2019年~2023年)及預測(2024年~2031年)

第15章 所使用的假設和縮寫

第16章 調查手法

簡介目錄
Product Code: PMRREP12325

Persistence Market Research has recently released an in-depth report on the global market for cardiac arrhythmia monitoring devices. This comprehensive analysis provides valuable insights into key market dynamics, including growth drivers, trends, opportunities, and challenges. The research offers exclusive data and projections for the global cardiac arrhythmia monitoring devices market, outlining the expected growth trajectory from 2024 to 2031.

Key Insights:

  • Cardiac Arrhythmia Monitoring Devices Market Size (2024E): US$ 8493.2 Mn
  • Projected Market Value (2031F): US$ 14369 Mn
  • Global Market Growth Rate (CAGR 2024 to 2031): 7.80%

Cardiac Arrhythmia Monitoring Devices Market - Report Scope:

Cardiac arrhythmia monitoring devices are essential tools for diagnosing and managing irregular heartbeats. These devices are used to track heart rhythm, detect abnormalities, and provide timely interventions to manage arrhythmias. The market includes various types of devices such as Holter monitors, electrocardiogram (ECG) devices, and implantable cardiac monitors, serving healthcare providers to improve patient outcomes and monitor heart health.

Market Growth Drivers:

The global cardiac arrhythmia monitoring devices market is experiencing robust growth driven by several factors, including the increasing prevalence of heart diseases, rising awareness about arrhythmias, and advancements in medical technology. The growing geriatric population, which is more prone to cardiovascular conditions, further accelerates market demand. Additionally, the rise in healthcare expenditure, improved healthcare infrastructure, and increasing adoption of wearable health monitoring devices contribute significantly to the market's expansion. The adoption of telemedicine and remote monitoring for arrhythmia management also plays a pivotal role in expanding the market reach, especially in underserved regions.

Market Restraints:

Despite the positive growth outlook, the cardiac arrhythmia monitoring devices market faces challenges such as high device costs, particularly for advanced diagnostic tools, which may limit adoption in emerging markets. Regulatory hurdles and the need for compliance with stringent health and safety standards also pose barriers to market entry. Additionally, the lack of trained professionals in certain regions to operate and interpret the data from these devices may hinder the market's overall growth.

Market Opportunities:

The cardiac arrhythmia monitoring devices market offers significant growth opportunities, particularly through the development of portable and wearable devices that provide real-time monitoring and data sharing capabilities. The growing trend toward personalized healthcare, coupled with advancements in artificial intelligence and machine learning to analyze arrhythmia data, opens new avenues for innovation in monitoring devices. Furthermore, increasing partnerships between device manufacturers and healthcare providers to offer integrated solutions and enhance patient care represents another promising opportunity for market players.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global cardiac arrhythmia monitoring devices market?
  • Which device types and technologies are seeing the most adoption across different healthcare settings?
  • How are advancements in AI and telemedicine reshaping the competitive landscape of the cardiac arrhythmia monitoring devices market?
  • Who are the key players in the market, and what strategies are they using to maintain competitive advantage?
  • What are the emerging trends and future prospects in the global cardiac arrhythmia monitoring devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global cardiac arrhythmia monitoring devices market, such as Medtronic, Abbott Laboratories, Boston Scientific, and Philips Healthcare, are focused on innovation, technological advancements, and strategic partnerships to strengthen their market positions. These companies invest in R&D to develop new monitoring devices that offer enhanced accuracy, portability, and ease of use. Collaborations with healthcare institutions and regulatory agencies are essential for ensuring compliance and gaining market acceptance. Additionally, the increasing focus on remote patient monitoring and the growing trend of home healthcare provide further opportunities for expansion and product diversification.

Key Companies Profiled:

  • NUUBO Smart Solutions Technologies, SL
  • Koninklijke Philips N.V.
  • GE Healthcare (General Electric Company)
  • Welch Allyn - A Hill-Rom Inc. Company
  • Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
  • Nihon Kohden Corporation
  • Fukuda Denshi Co., Ltd.
  • Biotelemetry, Inc.
  • AliveCor, Inc.
  • Biotronik, Inc.
  • Medronic, Plc.
  • St. Jude Medical, LLC. (Abbott Laboratories)

Market Taxonomy

By Product type

  • Implantable Cardiac Monitors
  • Resting ECG Devices
  • ECG Stress Test Devices
  • Mobile Cardiac Telemetry Monitors
  • Holter Monitors

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Homecare Settings
  • Long Term Care Centers
  • Emergency Medical Services

By Application

  • Atrial Fibrillation
  • Bradycardia
  • Conduction Disorders
  • Premature Contraction
  • Tachycardia
  • Ventricular Fibrillation

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Regulatory Scenario
  • 2.4. Pricing Analysis

3. Cardiac Arrhythmia Monitoring Devices Market View Point

  • 3.1. Macro-Economic Factors
  • 3.2. Opportunity Analysis
  • 3.3. Drivers
  • 3.4. Restraints
  • 3.5. Trends

4. North America Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031

  • 4.1. Introduction
  • 4.2. Historical Market Size (US$ Mn) By Country, 2019-2023
    • 4.2.1. U.S.
    • 4.2.2. Canada
  • 4.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2019-2023
    • 4.4.1. Implantable Cardiac Monitors
    • 4.4.2. Resting ECG Devices
    • 4.4.3. ECG Stress Test Devices
    • 4.4.4. Mobile Cardiac Telemetry Monitors
    • 4.4.5. Holter Monitors
  • 4.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 4.5.1. Implantable Cardiac Monitors
    • 4.5.2. Resting ECG Devices
    • 4.5.3. ECG Stress Test Devices
    • 4.5.4. Mobile Cardiac Telemetry Monitors
    • 4.5.5. Holter Monitors
  • 4.6. Historical Market Size (US$ Mn) By Application, 2019-2023
    • 4.6.1. Atrial Fibrillation
    • 4.6.2. Bradycardia
    • 4.6.3. Conduction Disorders
    • 4.6.4. Premature Contraction
    • 4.6.5. Tachycardia
    • 4.6.6. Ventricular Fibrillation
    • 4.6.7. Others
  • 4.7. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 4.7.1. Atrial Fibrillation
    • 4.7.2. Bradycardia
    • 4.7.3. Conduction Disorders
    • 4.7.4. Premature Contraction
    • 4.7.5. Tachycardia
    • 4.7.6. Ventricular Fibrillation
    • 4.7.7. Others
  • 4.8. Historical Market Size (US$ Mn) By End User, 2019-2023
    • 4.8.1. Hospitals
    • 4.8.2. Ambulatory Surgical Centers
    • 4.8.3. Diagnostic Centers
    • 4.8.4. Homecare Settings
    • 4.8.5. Long Term Care Centers
    • 4.8.6. Emergency Medical Services
  • 4.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 4.9.1. Hospitals
    • 4.9.2. Ambulatory Surgical Centers
    • 4.9.3. Diagnostic Centers
    • 4.9.4. Homecare Settings
    • 4.9.5. Long Term Care Centers
    • 4.9.6. Emergency Medical Services
  • 4.10. Drivers and Restraints: Impact Analysis
  • 4.11. Market Attractiveness Analysis
    • 4.11.1. By Country
    • 4.11.2. By Product Type
    • 4.11.3. By Application
    • 4.11.4. By End User
  • 4.12. Key Representative Market Participants
  • 4.13. Key Participants Market Presence (Intensity Map)

5. Latin America Cardiac Arrhythmia Monitoring Devices Market 2019-2023 and Forecast 2024-2031

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn) By Country, 2019-2023
    • 5.2.1. Brazil
    • 5.2.2. Mexico
    • 5.2.3. Rest of Latin America
  • 5.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Rest of Latin America
  • 5.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2019-2023
    • 5.4.1. Implantable Cardiac Monitors
    • 5.4.2. Resting ECG Devices
    • 5.4.3. ECG Stress Test Devices
    • 5.4.4. Mobile Cardiac Telemetry Monitors
    • 5.4.5. Holter Monitors
  • 5.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 5.5.1. Implantable Cardiac Monitors
    • 5.5.2. Resting ECG Devices
    • 5.5.3. ECG Stress Test Devices
    • 5.5.4. Mobile Cardiac Telemetry Monitors
    • 5.5.5. Holter Monitors
  • 5.6. Historical Market Size (US$ Mn) By Application, 2019-2023
    • 5.6.1. Atrial Fibrillation
    • 5.6.2. Bradycardia
    • 5.6.3. Conduction Disorders
    • 5.6.4. Premature Contraction
    • 5.6.5. Tachycardia
    • 5.6.6. Ventricular Fibrillation
    • 5.6.7. Others
  • 5.7. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 5.7.1. Atrial Fibrillation
    • 5.7.2. Bradycardia
    • 5.7.3. Conduction Disorders
    • 5.7.4. Premature Contraction
    • 5.7.5. Tachycardia
    • 5.7.6. Ventricular Fibrillation
    • 5.7.7. Others
  • 5.8. Historical Market Size (US$ Mn) By End User, 2019-2023
    • 5.8.1. Hospitals
    • 5.8.2. Ambulatory Surgical Centers
    • 5.8.3. Diagnostic Centers
    • 5.8.4. Homecare Settings
    • 5.8.5. Long Term Care Centers
    • 5.8.6. Emergency Medical Services
  • 5.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 5.9.1. Hospitals
    • 5.9.2. Ambulatory Surgical Centers
    • 5.9.3. Diagnostic Centers
    • 5.9.4. Homecare Settings
    • 5.9.5. Long Term Care Centers
    • 5.9.6. Emergency Medical Services
  • 5.10. Drivers and Restraints: Impact Analysis
  • 5.11. Market Attractiveness Analysis
    • 5.11.1. By Country
    • 5.11.2. By Product Type
    • 5.11.3. By Application
    • 5.11.4. By End User
  • 5.12. Key Representative Market Participants
  • 5.13. Key Participants Market Presence (Intensity Map)

6. Europe Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) By Country, 2019-2023
    • 6.2.1. Germany
    • 6.2.2. U.K.
    • 6.2.3. France
    • 6.2.4. Italy
    • 6.2.5. Spain
    • 6.2.6. Poland
    • 6.2.7. Russia
    • 6.2.8. Rest of Europe
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 6.3.1. Germany
    • 6.3.2. U.K.
    • 6.3.3. France
    • 6.3.4. Italy
    • 6.3.5. Spain
    • 6.3.6. Poland
    • 6.3.7. Russia
    • 6.3.8. Rest of Europe
  • 6.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2019-2023
    • 6.4.1. Implantable Cardiac Monitors
    • 6.4.2. Resting ECG Devices
    • 6.4.3. ECG Stress Test Devices
    • 6.4.4. Mobile Cardiac Telemetry Monitors
    • 6.4.5. Holter Monitors
  • 6.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 6.5.1. Implantable Cardiac Monitors
    • 6.5.2. Resting ECG Devices
    • 6.5.3. ECG Stress Test Devices
    • 6.5.4. Mobile Cardiac Telemetry Monitors
    • 6.5.5. Holter Monitors
  • 6.6. Historical Market Size (US$ Mn) By Application, 2019-2023
    • 6.6.1. Atrial Fibrillation
    • 6.6.2. Bradycardia
    • 6.6.3. Conduction Disorders
    • 6.6.4. Premature Contraction
    • 6.6.5. Tachycardia
    • 6.6.6. Ventricular Fibrillation
    • 6.6.7. Others
  • 6.7. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 6.7.1. Atrial Fibrillation
    • 6.7.2. Bradycardia
    • 6.7.3. Conduction Disorders
    • 6.7.4. Premature Contraction
    • 6.7.5. Tachycardia
    • 6.7.6. Ventricular Fibrillation
    • 6.7.7. Others
  • 6.8. Historical Market Size (US$ Mn) By End User, 2019-2023
    • 6.8.1. Hospitals
    • 6.8.2. Ambulatory Surgical Centers
    • 6.8.3. Diagnostic Centers
    • 6.8.4. Homecare Settings
    • 6.8.5. Long Term Care Centers
    • 6.8.6. Emergency Medical Services
  • 6.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 6.9.1. Hospitals
    • 6.9.2. Ambulatory Surgical Centers
    • 6.9.3. Diagnostic Centers
    • 6.9.4. Homecare Settings
    • 6.9.5. Long Term Care Centers
    • 6.9.6. Emergency Medical Services
  • 6.10. Drivers and Restraints: Impact Analysis
  • 6.11. Market Attractiveness Analysis
    • 6.11.1. By Country
    • 6.11.2. By Product Type
    • 6.11.3. By Application
    • 6.11.4. By End User
  • 6.12. Key Representative Market Participants
  • 6.13. Key Participants Market Presence (Intensity Map)

7. Asia Pacific (APAC) Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) By Country, 2019-2023
    • 7.2.1. China
    • 7.2.2. India
    • 7.2.3. Japan
    • 7.2.4. Australia and New Zealand
    • 7.2.5. Rest of APAC
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 7.3.1. China
    • 7.3.2. India
    • 7.3.3. Japan
    • 7.3.4. Australia and New Zealand
    • 7.3.5. Rest of APAC
  • 7.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2019-2023
    • 7.4.1. Implantable Cardiac Monitors
    • 7.4.2. Resting ECG Devices
    • 7.4.3. ECG Stress Test Devices
    • 7.4.4. Mobile Cardiac Telemetry Monitors
    • 7.4.5. Holter Monitors
  • 7.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 7.5.1. Implantable Cardiac Monitors
    • 7.5.2. Resting ECG Devices
    • 7.5.3. ECG Stress Test Devices
    • 7.5.4. Mobile Cardiac Telemetry Monitors
    • 7.5.5. Holter Monitors
  • 7.6. Historical Market Size (US$ Mn) By Application, 2019-2023
    • 7.6.1. Atrial Fibrillation
    • 7.6.2. Bradycardia
    • 7.6.3. Conduction Disorders
    • 7.6.4. Premature Contraction
    • 7.6.5. Tachycardia
    • 7.6.6. Ventricular Fibrillation
    • 7.6.7. Others
  • 7.7. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 7.7.1. Atrial Fibrillation
    • 7.7.2. Bradycardia
    • 7.7.3. Conduction Disorders
    • 7.7.4. Premature Contraction
    • 7.7.5. Tachycardia
    • 7.7.6. Ventricular Fibrillation
    • 7.7.7. Others
  • 7.8. Historical Market Size (US$ Mn) By End User, 2019-2023
    • 7.8.1. Hospitals
    • 7.8.2. Ambulatory Surgical Centers
    • 7.8.3. Diagnostic Centers
    • 7.8.4. Homecare Settings
    • 7.8.5. Long Term Care Centers
    • 7.8.6. Emergency Medical Services
  • 7.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 7.9.1. Hospitals
    • 7.9.2. Ambulatory Surgical Centers
    • 7.9.3. Diagnostic Centers
    • 7.9.4. Homecare Settings
    • 7.9.5. Long Term Care Centers
    • 7.9.6. Emergency Medical Services
  • 7.10. Drivers and Restraints: Impact Analysis
  • 7.11. Market Attractiveness Analysis
    • 7.11.1. By Country
    • 7.11.2. By Product Type
    • 7.11.3. By Application
    • 7.11.4. By End User
  • 7.12. Key Representative Market Participants
  • 7.13. Key Participants Market Presence (Intensity Map)

8. Middle East and Africa (MEA) Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) By Country, 2019-2023
    • 8.2.1. GCC Countries
    • 8.2.2. South Africa
    • 8.2.3. Rest of MEA
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2024-2031
    • 8.3.1. GCC Countries
    • 8.3.2. South Africa
    • 8.3.3. Rest of MEA
  • 8.4. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Product Type, 2019-2023
    • 8.4.1. Implantable Cardiac Monitors
    • 8.4.2. Resting ECG Devices
    • 8.4.3. ECG Stress Test Devices
    • 8.4.4. Mobile Cardiac Telemetry Monitors
    • 8.4.5. Holter Monitors
  • 8.5. Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2024-2031
    • 8.5.1. Implantable Cardiac Monitors
    • 8.5.2. Resting ECG Devices
    • 8.5.3. ECG Stress Test Devices
    • 8.5.4. Mobile Cardiac Telemetry Monitors
    • 8.5.5. Holter Monitors
  • 8.6. Historical Market Size (US$ Mn) By Application, 2019-2023
    • 8.6.1. Atrial Fibrillation
    • 8.6.2. Bradycardia
    • 8.6.3. Conduction Disorders
    • 8.6.4. Premature Contraction
    • 8.6.5. Tachycardia
    • 8.6.6. Ventricular Fibrillation
    • 8.6.7. Others
  • 8.7. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 8.7.1. Atrial Fibrillation
    • 8.7.2. Bradycardia
    • 8.7.3. Conduction Disorders
    • 8.7.4. Premature Contraction
    • 8.7.5. Tachycardia
    • 8.7.6. Ventricular Fibrillation
    • 8.7.7. Others
  • 8.8. Historical Market Size (US$ Mn) By End User, 2019-2023
    • 8.8.1. Hospitals
    • 8.8.2. Ambulatory Surgical Centers
    • 8.8.3. Diagnostic Centers
    • 8.8.4. Homecare Settings
    • 8.8.5. Long Term Care Centers
    • 8.8.6. Emergency Medical Services
  • 8.9. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 8.9.1. Hospitals
    • 8.9.2. Ambulatory Surgical Centers
    • 8.9.3. Diagnostic Centers
    • 8.9.4. Homecare Settings
    • 8.9.5. Long Term Care Centers
    • 8.9.6. Emergency Medical Services
  • 8.10. Drivers and Restraints: Impact Analysis
  • 8.11. Market Attractiveness Analysis
    • 8.11.1. By Country
    • 8.11.2. By Product Type
    • 8.11.3. By Application
    • 8.11.4. By End User
  • 8.12. Key Representative Market Participants
  • 8.13. Key Participants Market Presence (Intensity Map)

9. Competition Landscape

  • 9.1. Market Structure
  • 9.2. Competition Dashboard
  • 9.3. Company Profiles (Details - Overview, Financials, Strategy, SWOT, Recent Developments)
    • 9.3.1. NUUBO Smart Solutions Technologies, SL
    • 9.3.2. Koninklijke Philips N.V.
    • 9.3.3. GE Healthcare (General Electric Company)
    • 9.3.4. Welch Allyn - A Hill-Rom Inc. Company
    • 9.3.5. Spacelabs Healthcare, Inc. (OSI Systems, Inc.)
    • 9.3.6. Nihon Kohden Corporation
    • 9.3.7. Fukuda Denshi Co., Ltd.
    • 9.3.8. Biotelemetry, Inc.
    • 9.3.9. AliveCor, Inc.
    • 9.3.10. Biotronik, Inc.
    • 9.3.11. Medronic, Plc.
    • 9.3.12. St. Jude Medical, LLC. (Abbott Laboratories)

10. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size Analysis 2019-2023, By Region
    • 10.2.1. North America
    • 10.2.2. Latin America
    • 10.2.3. Europe
    • 10.2.4. Asia Pacific (APAC)
    • 10.2.5. Middle East and Africa (MEA)
  • 10.3. Market Size Analysis 2024-2031, By Region
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. Asia Pacific (APAC)
    • 10.3.5. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Product Type

  • 11.1. Introduction/Key Findings
  • 11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product Type, 2019-2023
    • 11.2.1. Implantable Cardiac Monitors
    • 11.2.2. Resting ECG Devices
    • 11.2.3. ECG stress Test Devices
    • 11.2.4. Mobile Cardiac Telemetry Monitors
    • 11.2.5. Holter Monitors
  • 11.3. Market Size (US$ Mn) and Volume and Forecast By Product Type, 2024-2031
    • 11.3.1. Implantable Cardiac Monitors
    • 11.3.2. Resting ECG Devices
    • 11.3.3. ECG stress Test Devices
    • 11.3.4. Mobile Cardiac Telemetry Monitors
    • 11.3.5. Holter Monitors
  • 11.4. Market Attractiveness Analysis By Product Type

12. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By Application

  • 12.1. Introduction/Key Findings
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2019-2023
    • 12.2.1. Atrial Fibrillation
    • 12.2.2. Bradycardia
    • 12.2.3. Conduction Disorders
    • 12.2.4. Premature Contraction
    • 12.2.5. Tachycardia
    • 12.2.6. Ventricular Fibrillation
    • 12.2.7. Others
  • 12.3. Market Size (US$ Mn) Forecast By Application, 2024-2031
    • 12.3.1. Atrial Fibrillation
    • 12.3.2. Bradycardia
    • 12.3.3. Conduction Disorders
    • 12.3.4. Premature Contraction
    • 12.3.5. Tachycardia
    • 12.3.6. Ventricular Fibrillation
    • 12.3.7. Others
  • 12.4. Market Attractiveness Analysis By Application

13. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031, By End User

  • 13.1. Introduction/Key Findings
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2019-2023
    • 13.2.1. Hospitals
    • 13.2.2. Ambulatory Surgical Centers
    • 13.2.3. Diagnostic Centers
    • 13.2.4. Homecare Settings
    • 13.2.5. Long Term Care Centers
    • 13.2.6. Emergency Medical Services
  • 13.3. Market Size (US$ Mn) Forecast By End User, 2024-2031
    • 13.3.1. Hospitals
    • 13.3.2. Ambulatory Surgical Centers
    • 13.3.3. Diagnostic Centers
    • 13.3.4. Homecare Settings
    • 13.3.5. Long Term Care Centers
    • 13.3.6. Emergency Medical Services
  • 13.4. Market Attractiveness Analysis By End User

14. Global Cardiac Arrhythmia Monitoring Devices Market Analysis 2019-2023 and Forecast 2024-2031

  • 14.1. Market Size and Y-o-Y Growth
  • 14.2. Absolute $ Opportunity

15. Assumptions and Acronyms Used

16. Research Methodology